Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma
- 13 May 2016
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 36 (1), 419-427
- https://doi.org/10.3892/or.2016.4807
Abstract
B7-H4, as a member of the costimulatory B7 family, serves a critical role in the negative regulation of T cell-mediated antitumor immune responses. Cholangiocarcinoma (CCA) has a poor prognosis due its invasiveness and associated metastasis. The present study investigated the expression of B7-H4 in patients with CCA and its association with patient prognosis. The correlation between B7-H4 expression and CD4+ and CD8+ tumor-infiltrating lymphocytes was also investigated. The results demonstrated that high B7-H4 expression was detected in cancer tissues (54/110; 49.1%) compared with that noted in chronic inflammatory bile duct tissues (4/19; 21.1%). Furthermore, all 8 biliary adenoma samples showed negative staining. The expression of B7-H4 was significantly associated with adverse clinical and pathological features including histologic grade (P<0.001), tumor status (P=0.025), lymph node metastasis (P=0.035) and 6th Union for International Cancer Control stage (P=0.019). Kaplan‑Meier survival analysis and Cox regression analysis indicated that aberrant B7-H4 expression was a significant independent predictor of poor overall survival and early recurrence. In addition, the present study demonstrated that B7-H4 expression in tumor cells was negatively correlated with the density of CD8+ T cells in the tumor stroma. Co-culture assays indicated that knockdown of B7-H4 increased CD8+ T cell-mediated cytotoxicity in vitro, suggesting that the expression of B7-H4 may serve a role in shielding tumors from immune surveillance by suppression of tumor-infiltrating CD8+ T lymphocytes in CCA. In conclusion, the present study showed that aberrant expression of B7-H4 was correlated with poorer prognosis and suppressed CD8+ tumor‑infiltrating lymphocytes in CCA.Keywords
This publication has 33 references indexed in Scilit:
- Risk factors for perihilar cholangiocarcinoma: A hospital‐based case–control studyLiver International, 2014
- Treatment and Prognosis for Patients With Intrahepatic CholangiocarcinomaJAMA Surgery, 2014
- Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinomaEuropean Journal of Cancer, 2013
- Expression of Costimulatory Molecule B7-H4 in Human Malignant TumorsOnkologie, 2012
- The Immunohistochemical Analysis of RCAS1, HLA-G, and B7H4-Positive Macrophages in Partial and Complete Hydatidiform Mole in Both Applied Therapeutic Surgery and Surgery Followed by ChemotherapyAmerican Journal of Reproductive Immunology, 2011
- The complex role of B7 molecules in tumor immunologyTrends in Molecular Medicine, 2008
- B7-H4 Is Highly Expressed in Ductal and Lobular Breast CancerClinical Cancer Research, 2005
- Surgical Management of CholangiocarcinomaSeminars in Liver Disease, 2004
- B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell ImmunityImmunity, 2003
- B7S1, a Novel B7 Family Member that Negatively Regulates T Cell ActivationImmunity, 2003